Diagnosis, management and prevention of ventilator-associated pneumonia: An update

Drugs

Volumn 70, Issue 15, 2010, Pages 1927-1944

  Vincent, Jean Louis ^a   De Souza Barros, Dalton ^a   Cianferoni, Silvia ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Amikacin; Amoxicillinclavulanic acid; Cefepime; Cefotaxime; Ceftazidime; Cefuroxime; Ciprofloxacin; Ertapenem; Gentamicin; Imipenemcilastatin; Levofloxacin; Linezolid; Meropenem; Nosocomial pneumonia; Piperacillintazobactam; Selective gastrointestinal decontamination; Vancomycin

Indexed keywords

AMIKACIN; AMINOPENICILLIN; AMOXICILLIN; BETA LACTAMASE INHIBITOR; C REACTIVE PROTEIN; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CILASTATIN; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; COLISTIN; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN; PRAVASTATIN; PROBIOTIC AGENT; PROCALCITONIN; SERUM AMYLOID A; TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER; AEROSOL; ANTIMICROBIAL THERAPY; BRONCHOSCOPY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; EARLY INTERVENTION; ENTEROBACTER; ESCHERICHIA COLI; FEVER; HAEMOPHILUS INFLUENZAE; HEAT TREATMENT; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HUMIDIFIER; INFECTION PREVENTION; INVASIVE PROCEDURE; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS; LEUKOCYTOSIS; LUNG BIOPSY; LUNG LAVAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; MORBIDITY; MORTALITY; MOUTH HYGIENE; NON INVASIVE PROCEDURE; PATIENT POSITIONING; POSITIVE END EXPIRATORY PRESSURE; PROTEUS; PSEUDOMONAS AERUGINOSA; REVIEW; SERRATIA MARCESCENS; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; TRACHEOTOMY; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; CLINICAL PROTOCOLS; CROSS INFECTION; EARLY DIAGNOSIS; HUMANS; PNEUMONIA, VENTILATOR-ASSOCIATED;

BACTERIA (MICROORGANISMS);

EID: 77957705829     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11538080-000000000-00000     Document Type: Review

References (124)

1. Hortal J, Munoz P, Cuerpo G, et al. Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. Crit Care 2009; 13 (3): R80
2. Muscedere JG, Martin CM, Heyland DK. The impact of ventilator-associated pneumonia on the Canadian health care system. J Crit Care 2008; 23 (1): 5-10
3. Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33 (10): 2184-2193
4. van der Kooi TI, de Boer AS, Mannien J, et al. Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med 2007; 33 (2): 271-278
5. Koulenti D, Lisboa T, Brun-Buisson C, et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009; 37 (8): 2360-2368
6. Minei JP, Hawkins K, Moody B, et al. Alternative case definitions of ventilator-associated pneumonia identify different patients in a surgical intensive care unit. Shock 2000; 14 (3): 331-336
7. Suetens C,Morales I, Savey A, et al. European surveillance of ICU-acquired infections (HELICS-ICU): methods and main results. J Hosp Infect 2007; 65 Suppl. 2: 171-173
8. Torres A, Ewig S, Lode H, et al. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009; 35 (1): 9-29
9. Depuydt PO, Vandijck DM, Bekaert MA, et al. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated- pneumonia. Crit Care 2008; 12 (6): R142
10. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171 (4): 388-416
11. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128 (6): 3854-3862
12. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29 (11): 996-1011
13. Boots RJ, Lipman J, Bellomo R, et al. The spectrum of practice in the diagnosis and management of pneumonia in patients requiring mechanical ventilation: Australian and New Zealand practice in intensive care (ANZPIC II). Anaesth Intensive Care 2005; 33 (1): 87-100
14. Park DR. The microbiology of ventilator-associated pneumonia. Respir Care 2005; 50 (6): 742-763
15. Rosenthal VD, Maki DG, Jamulitrat S, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control 2010; 38 (2): 95-104
16. Póvoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005; 11 (2): 101-108
17. Póvoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005; 25 (5): 804-812
18. Ramirez P, Garcia MA, Ferrer M, et al. Sequential measurements of procalcitonin levels in diagnosing ventilatorassociated pneumonia. Eur Respir J 2008; 31 (2): 356-362
19. Seligman R, Meisner M, Lisboa TC, et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006; 10 (5): R125
20. Lisboa T, Seligman R, Diaz E, et al. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med 2008; 36 (1): 166-171
21. Luyt CE, Combes A, Reynaud C, et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008; 34 (8): 1434-1440
22. Luyt CE, Guerin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005; 171 (1): 48-53
23. Hillas G, Vassilakopoulos T, Plantza P, et al. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator- associated pneumonia. Eur Respir J 2010; 35 (4): 805-811
24. McDunn JE, Husain KD, Polpitiya AD, et al. Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram. PLoS One 2008; 3 (2): e1564
25. Cobb JP, Moore EE, Hayden DL, et al. Validation of the riboleukogram to detect ventilator-associated pneumonia after severe injury. Ann Surg. Epub 2009 Aug 27
26. Mentec H, May-Michelangeli L, Rabbat A, et al. Blind and bronchoscopic sampling methods in suspected ventilatorassociated pneumonia: a multicentre prospective study. Intensive Care Med 2004; 30 (7): 1319-1326
27. Leo A, Galindo-Galindo J, Folch E, et al. Comparison of bronchoscopic bronchoalveolar lavage vs blind lavage with a modified nasogastric tube in the etiologic diagnosis of ventilator-associated pneumonia. Med Intensiva 2008; 32 (3): 115-120
28. Conway Morris A, Kefala K, Wilkinson TS, et al. Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax 2010; 65 (3): 201-207
29. Determann RM, Millo JL, Gibot S, et al. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 2005; 31 (11): 1495-1500
30. Anand NJ, Zuick S, Klesney-Tait J, et al. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009; 135 (3): 641-647
31. Oudhuis GJ, Beuving J, Bergmans D, et al. Soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilatorassociated pneumonia. Intensive Care Med 2009; 35 (7): 1265-1270
32. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator- associated pneumonia: a randomized trial. Ann Intern Med 2000; 132 (8): 621-630
33. Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006; 355 (25): 2619-2630
34. Marik PE, Baram M. Diagnosis of ventilator-associated pneumonia. N Engl J Med 2007; 356 (14): 1470-1471
35. Fujitani S, Cohen-Melamed MH, Tuttle RP, et al. Comparison of semi-quantitative endotracheal aspirates to quantitative non-bronchoscopic bronchoalveolar lavage in diagnosing ventilator-associated pneumonia. Respir Care 2009; 54 (11): 1453-1461
36. Mondi MM, Chang MC, Bowton DL, et al. Prospective comparison of bronchoalveolar lavage and quantitative deep tracheal aspirate in the diagnosis of ventilator associated pneumonia. J Trauma 2005; 59 (4): 891-895
37. Brun-Buisson C, Fartoukh M, Lechapt E, et al. Contribution of blinded, protected quantitative specimens to the diagnostic and therapeutic management of ventilatorassociated pneumonia. Chest 2005; 128 (2): 533-544
38. Shorr AF, Sherner JH, Jackson WL, et al. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2005; 33 (1): 46-53
39. Berton DC, Kalil AC, Cavalcanti M, et al. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev 2008; (4): CD006482
40. Muscedere J, Dodek P, Keenan S, et al. Comprehensive evidence-based clinical practice guidelines for ventilatorassociated pneumonia: diagnosis and treatment. J Crit Care 2008; 23 (1): 138-147 (Pubitemid 351400356)
41. Luna CM, Aruj P, Niederman MS, et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006; 27 (1): 158-164
42. Teixeira PJ, Seligman R, Hertz FT, et al. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes. J Hosp Infect 2007; 65 (4): 361-367
43. Kuti EL, Patel AA, Coleman CI. Impact of inappropriate antibiotic therapy on mortality in patients with ventilatorassociated pneumonia and blood stream infection: a meta-analysis. J Crit Care 2008; 23 (1): 91-100
44. Micek ST, Ward S, Fraser VJ, et al. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004; 125 (5): 1791-1799
45. Eachempati SR, Hydo LJ, Shou J, et al. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? J Trauma 2009; 66 (5): 1343-1348
46. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006; 129 (5): 1210-1218
47. Wunderink RG, Rello J, Cammarata SK, et al. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003; 124 (5): 1789-1797
48. Wunderink RG, Mendelson MH, Somero MS, et al. Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus. Chest 2008; 134 (6): 1200-1207
49. Boselli E, Breilh D, Rimmele T, et al. Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia. Crit Care Med 2008; 36 (5): 1500-1506
50. Damas P, Garweg C, Monchi M, et al. Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]. Crit Care 2006; 10 (2): R52
51. Garnacho-Montero J, Sa-Borges M, Sole-Violan J, et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 2007; 35 (8): 1888-1895
52. Heyland DK, Dodek P, Muscedere J, et al. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med 2008; 36 (3): 737-744
53. Papazian L. How can earlier antibiotic efficacy be provided for ventilator-associated pneumonia without promoting bacterial resistance? Is initial monotherapy or a combination of antibiotics the right answer? Crit Care Med 2008; 36 (3): 994-995
54. Aarts MA, Hancock JN, Heyland D, et al. Empiric antibiotic therapy for suspected ventilator-associated pneumonia: a systematic review and meta-analysis of randomized trials. Crit Care Med 2008; 36 (1): 108-117
55. Combes A, Luyt CE, Fagon JY, et al. Early predictors for infection recurrence and death in patients with ventilatorassociated pneumonia. Crit Care Med 2007; 35 (1): 146-154
56. Stolz D, Smyrnios N, Eggimann P, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J 2009; 34 (6): 1364-1375
57. Mueller EW, Croce MA, Boucher BA, et al. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator-associated pneumonia. J Trauma 2007; 63 (6): 1329-1337
58. Bouza E, Torres MV, Radice C, et al. Direct E-test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator-associated pneumonia. Clin Infect Dis 2007; 44 (3): 382-387
59. Shorr AF, Cook D, Jiang X, et al. Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial. J Crit Care 2008; 23 (1): 64-73
60. Hallal A, Cohn SM, Namias N, et al. Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. Surg Infect (Larchmt) 2007; 8 (1): 73-82
61. Michalopoulos A, Kasiakou SK, Mastora Z, et al. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005; 9 (1): R53-9
62. Michalopoulos A, Fotakis D, Virtzili S, et al. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir Med 2008; 102 (3): 407-412
63. Ioannidou E, Siempos II, Falagas ME. Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J Antimicrob Chemother 2007; 60 (6): 1216-1226
64. Giamarellos-Bourboulis EJ, Pechere JC, Routsi C, et al. Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clin Infect Dis 2008; 46 (8): 1157-1164
65. Siempos II, Vardakas KZ, Kopterides P, et al. Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother 2008; 62 (4): 661-668
66. Majumdar SR, McAlister FA, Eurich DT, et al. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006; 333 (7576): 999
67. Thomsen RW, Riis A, Kornum JB, et al. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med 2008; 168 (19): 2081-2087
68. Chalmers JD, Singanayagam A, Murray MP, et al. Prior statin use is associated with improved outcomes in community- acquired pneumonia. Am J Med 2008; 121 (11): 1002-1007
69. Kopterides P, Falagas ME. Statins for sepsis: a critical and updated review. Clin Microbiol Infect 2009; 15 (4): 325-334
70. Pravastatin and ventilatory associated pneumonia (EPRAVAP) [ClinicalTrials.gov identifier NCT00702130]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL: http://www.clinicaltrials.gov [Accessed 2010 Jul 29]
71. Vincent JL. Nosocomial infections in adult intensive-care units. Lancet 2003; 361 (9374): 2068-2077
72. Falagas ME, Siempos II, Bliziotis IA, et al. Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials. Crit Care 2006; 10 (4): R123
73. Manzano F, Fernandez-Mondejar E, Colmenero M, et al. Positive-end expiratory pressure reduces incidence of ventilator-associated pneumonia in nonhypoxemic patients. Crit Care Med 2008; 36 (8): 2225-2231
74. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial.AmJ Respir Crit Care Med. Epub 2010 Jun 3
75. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilatorassociated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 2010; 38 (3): 954-962
76. Barraud D, Blard C, Hein F, et al. Probiotics in the critically ill patient: a double blind, randomized, placebocontrolled trial. Intensive Care Med. Epub 2010 May 26
77. Quenot JP, Ladoire S, Devoucoux F, et al. Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia. Crit Care Med 2007; 35 (9): 2031-2036
78. Nseir S, Favory R, Jozefowicz E, et al. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study. Crit Care 2008; 12 (3): R62
79. Palmer LB, Smaldone GC, Chen JJ, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008; 36 (7): 2008-2013
80. Dallas J, Kollef M. VAT vs VAP: are we heading toward clarity or confusion? Chest 2009; 135 (2): 252-255
81. Terragni PP, AntonelliM, Fumagalli R, et al. Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. JAMA 2010; 303 (15): 1483-1489
82. Staudinger T, Bojic A, Holzinger U, et al. Continuous lateral rotation therapy to prevent ventilator-associated pneumonia. Crit Care Med 2010; 38 (2): 486-490
83. Alsaghir AH, Martin CM. Effect of prone positioning in patients with acute respiratory distress syndrome: a metaanalysis. Crit Care Med 2008; 36 (2): 603-609
84. Kopterides P, Siempos II, Armaganidis A. Prone positioning in hypoxemic respiratory failure: meta-analysis of randomized controlled trials. J Crit Care 2009; 24 (1): 89-100
85. Drakulovic MB, Torres A, Bauer TT, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999; 354 (9193): 1851-1858
86. Alexiou VG, Ierodiakonou V, Dimopoulos G, et al. Impact of patient position on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. J Crit Care 2009; 24 (4): 515-522
87. Vincent JL. Give your patient a fast hug (at least) once a day. Crit Care Med 2005; 33 (6): 1225-1229
88. Van Nieuwenhoven CA, Vandenbroucke-Grauls C, van Tiel FH, et al. Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study. Crit Care Med 2006; 34 (2): 396-402
89. Chao YF, Chen YY, Wang KW, et al. Removal of oral secretion prior to position change can reduce the incidence of ventilator-associated pneumonia for adult ICU patients: a clinical controlled trial study. J Clin Nurs 2009; 18 (1): 22-28
90. Lacherade JC, Auburtin M, Cerf C, et al. Impact of humidification systems on ventilator-associated pneumonia: a randomized multicenter trial. Am J Respir Crit Care Med 2005; 172 (10): 1276-1282
91. Boots RJ, George N, Faoagali JL, et al. Double-heaterwire circuits and heat-and-moisture exchangers and the risk of ventilator-associated pneumonia. Crit Care Med 2006; 34 (3): 687-693
92. Lorente L, Lecuona M, Jimenez A, et al. Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial [ISRCTN88724583]. Crit Care 2006; 10 (4): R116
93. Siempos II, Vardakas KZ, Kopterides P, et al. Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a meta-analysis of randomized controlled trials. Crit Care Med 2007; 35 (12): 2843-2851
94. Lorente L, Lecuona M, Martin MM, et al. Ventilatorassociated pneumonia using a closed versus an open tracheal suction system. Crit Care Med 2005; 33 (1): 115-119
95. Lorente L, Lecuona M, Jimenez A, et al. Tracheal suction by closed system without daily change versus open system. Intensive Care Med 2006; 32 (4): 538-544
96. Vonberg RP, Eckmanns T, Welte T, et al. Impact of the suctioning system (open vs. closed) on the incidence of ventilation-associated pneumonia: meta-analysis of randomized controlled trials. Intensive Care Med 2006; 32 (9): 1329-1335
97. Subirana M, Sola I, Benito S. Closed tracheal suction systems versus open tracheal suction systems for mechanically ventilated adult patients. Cochrane Database Syst Rev 2007; (4): CD004581
98. Jongerden IP, Rovers MM, Grypdonck MH, et al. Open and closed endotracheal suction systems in mechanically ventilated intensive care patients: a meta-analysis. Crit Care Med 2007; 35 (1): 260-270
99. Siempos II, Vardakas KZ, Falagas ME. Closed tracheal suction systems for prevention of ventilator-associated pneumonia. Br J Anaesth 2008; 100 (3): 299-306
100. Niel-Weise BS, Snoeren RL, van den Broek PJ. Policies for endotracheal suctioning of patients receiving mechanical ventilation: a systematic review of randomized controlled trials. Infect Control Hosp Epidemiol 2007; 28 (5): 531-536
101. Caruso P, Denari S, Ruiz SA, et al. Saline instillation before tracheal suctioning decreases the incidence of ventilatorassociated pneumonia. Crit Care Med 2009; 37 (1): 32-38
102. Dezfulian C, ShojaniaK, CollardHR, et al. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med 2005; 118 (1): 11-18
103. Lorente L, Lecuona M, Jimenez A, et al. Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med 2007; 176 (11): 1079-1083
104. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008; 300 (7): 805-813
105. Chastre J. Preventing ventilator-associated pneumonia: could silver-coated endotracheal tubes be the answer? JAMA 2008; 300 (7): 842-844
106. Kollef M, Pittet D, Sanchez GM, et al. A randomized double-blind trial of iseganan in prevention of ventilatorassociated pneumonia. Am J Respir Crit Care Med 2006; 173 (1): 91-97
107. Fourrier F, Dubois D, Pronnier P, et al. Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-controlled multicenter study. Crit Care Med 2005; 33 (8): 1728-1735
108. Seguin P, Tanguy M, Laviolle B, et al. Effect of oropharyngeal decontamination by povidone-iodine on ventilator- associated pneumonia in patients with head trauma. Crit Care Med 2006; 34 (5): 1514-1519
109. Koeman M, van der Ven AJ, Hak E, et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006; 173 (12): 1348-1355
110. Tantipong H, Morkchareonpong C, Jaiyindee S, et al. Randomized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2008; 29 (2): 131-136
111. Chan EY, Ruest A, Meade MO, et al. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ 2007; 334 (7599): 889
112. Panchabhai TS, Dangayach NS, Krishnan A, et al. Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open-label randomized trial with 0.01% potassium permanganate as control. Chest 2009; 135 (5): 1150-1156
113. Bellissimo-Rodrigues F, Bellissimo-Rodrigues WT, Viana JM, et al. Effectiveness of oral rinse with chlorhexidine in preventing nosocomial respiratory tract infections among intensive care unit patients. Infect Control Hosp Epidemiol 2009; 30 (10): 952-958
114. Scannapieco FA, Yu J, Raghavendran K, et al. A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients. Crit Care 2009; 13 (4): R117
115. Miller RS, Norris PR, Jenkins JM, et al. Systems initiatives reduce healthcare-associated infections: a study of 22,928 device days in a single trauma unit. J Trauma 2010; 68 (1): 23-31
116. Papadimos TJ, Hensley SJ, Duggan JM, et al. Implementation of the FASTHUG concept decreases the incidence of ventilator-associated pneumonia in a surgical intensive care unit. Patient Saf Surg 2008; 2: 3
117. Zaydfudim V, Dossett LA, Starmer JM, et al. Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle. Arch Surg 2009; 144 (7): 656-662
118. Weireter Jr LJ, Collins JN, Britt RC, et al. Impact of a monitored program of care on incidence of ventilatorassociated pneumonia: results of a longterm performanceimprovement project. J Am Coll Surg 2009; 208 (5): 700-704
119. Marra AR, Cal RG, Silva CV, et al. Successful prevention of ventilator-associated pneumonia in an intensive care setting. Am J Infect Control 2009; 37 (8): 619-625
120. Bonello RS, Fletcher CE, Becker WK, et al. An intensive care unit quality improvement collaborative in nine Department of Veterans Affairs hospitals: reducing ventilator- associated pneumonia and catheter-related bloodstream infection rates. Jt Comm J Qual Patient Saf 2008; 34 (11): 639-645
121. Bloos F, Muller S, Harz A, et al. Effects of staff training on the care of mechanically ventilated patients: a prospective cohort study. Br J Anaesth 2009; 103 (2): 232-237
122. Omrane R, Eid J, Perreault MM, et al. Impact of a protocol for prevention of ventilator-associated pneumonia. Ann Pharmacother 2007; 41 (9): 1390-1396
123. Klompas M. The paradox of ventilator-associated pneumonia prevention measures. Crit Care 2009; 13 (5): 315
124. KlompasM, Platt R. Ventilator-associated pneumonia: the wrong quality measure for benchmarking. Ann Intern Med 2007; 147 (11): 803-805